Cost effectiveness of cyclosporine (CsA), rapamune (RAPA), and tacrolimus (TAC) in combination with mycophenolate mofetil (MMF) in cadaveric renal transplants.

被引：0
|
作者：
Siddiqi, N [1 ]
Hussain, SA [1 ]
Hariharan, S [1 ]
机构：
[1] Med Coll Wisconsin, Div Nephrol, Milwaukee, WI 53226 USA
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2004年 / 4卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
1322
引用
收藏
页码：520 / 520
页数：1
相关论文
共 34 条
  • [1] Cyclosporine A (CSA) vs. tacrolimus (TAC), in combination with mycophenolate mofetil (MMF) and steroids as primary immunosuppression after lung transplantation
    Zuckermann, A
    Reichenspurner, H
    Klepetko, W
    Meiser, B
    Birsan, T
    Treede, H
    Kupilik, N
    Wisser, W
    TRANSPLANTATION, 1999, 67 (07) : S236 - S236
  • [2] Safety and efficacy of tacrolimus in combination with mycophenolate mofetil (MMF) in cadaveric renal transplant recipients
    Miller, J
    Mendez, R
    Pirsch, JD
    Jensik, SC
    TRANSPLANTATION, 2000, 69 (05) : 875 - 880
  • [3] Comparison of early use of tacrolimus-rapamycin (Tac-Rapa) versus tacrolimus-mycophenolate mofetil (Tac-MMF) in renal transplantation.
    Velidedeoglu, E
    Krok, K
    Doyle, A
    Naji, A
    Grossman, R
    Markmann, J
    Bloom, R
    CLINICAL IMMUNOLOGY, 2002, 103 (03) : S147 - S147
  • [4] Randomized trial of tacrolimus in combination with mycophenolate mofetil versus cyclosporine with mycophenolate mofetil in cadaveric renal transplant recipients with delayed graft function
    Liu, B
    Lin, ZB
    Ming, CS
    Zhang, WJ
    Chen, ZS
    Sha, B
    Zeng, FJ
    Chen, S
    TRANSPLANTATION PROCEEDINGS, 2003, 35 (01) : 87 - 88
  • [5] Conversion of cyclosporine (neoral;: CsA) to mycophenolate mofetil (MMF) in stable renal transplant recipients.
    Schrama, YC
    Hené, RJ
    Boer, P
    Koomans, HA
    KIDNEY INTERNATIONAL, 1999, 55 (04) : 1625 - 1626
  • [6] Tacrolimus Can Induce Remission in Cyclosporine (CsA) and Mycophenolate Mofetil (MMF) Resistant Pediatric Onset Nephrotic Syndrome
    Ahmed, Heba Mostafa
    IRANIAN JOURNAL OF KIDNEY DISEASES, 2019, 13 (05) : 323 - 328
  • [7] Comparative analysis of renal function in patients with cadaveric kidney transplants treated with tacrolimus (TaC) or cyclosporin (CsA).
    Gonzalez-Molina, M
    Morales, JM
    Marcen, R
    Del Castillo, D
    Grinyo, JM
    Gil-Vernet, S
    Oppenheimer, F
    Campistol, JM
    Capdevila, L
    Lampreave, I
    Valdes, F
    Andres, A
    Anaya, F
    Escuin, F
    Arias, M
    Pallardo, L
    AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 : 344 - 345
  • [8] Comparison of four different steroid avoidance protocols in kidney transplanation: Tacrolimus (Tac)/mycophenolate mofetil(MMF) versus tae/sirolimus(SLR) versus cyclosporine(CSA)/mmf versus csajs']jslr.
    Kumar, MSA
    Heifets, M
    Fyfe, B
    Moritz, MJ
    Saeed, MI
    Parikh, MH
    Kumar, A
    AMERICAN JOURNAL OF TRANSPLANTATION, 2005, 5 : 286 - 287
  • [9] Randomized trial of tacrolimus (Prograf) in combination with azathioprine or mychophenolate mofetil versus cyclosporine (Neoral) with mycophenolate mofetil after cadaveric kidney transplantation
    Johnson, C
    Ahsan, N
    Gonwa, T
    Halloran, P
    Stegall, M
    Hardy, M
    Metzger, R
    Shield, C
    Rocher, L
    Scandling, J
    Sorensen, J
    Mulloy, L
    Light, J
    Corwin, C
    Danovitch, G
    Wachs, M
    VanVeldhuisen, P
    Salm, K
    Tolzman, D
    Fitzsimmons, WE
    TRANSPLANTATION, 2000, 69 (05) : 834 - 841
  • [10] Sirolimus (RAP) plus cyclosporine microemulsion (CSA) is associated with a greater risk for renal function deterioration vs. mycophenolate mofetil (MMF) plus CSA.
    Meier-Kriesche, HU
    Loveland, JJ
    Steffen, BJ
    Chu, AH
    Gotz, V
    Gordon, RD
    Morris, JA
    Kaplan, B
    AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 : 218 - 219
1234